M. Mark Melin MD FACS RPVI FACCWS, is Medical Director of the Gonda Vascular Center Wound Clinic, Mayo Clinic, Rochester, Minnesota. His interests and educational niches include management of lymphedema/lymphatic stasis in the wounded patient, the endothelial glycocalyx, adjunctive micronutrient and bionutrient application to wound care, diosmin hesperidin Micronized Purified Flavonoid Fraction (MPFF), wound pH and biofilm management, and emerging technologies in wound products.
Additional interests, educational efforts, presentations and research include human physiology and adaptability in the weightlessness of space travel and its translation to improving patient cares on terra firma and achieving nominal human function in environmental extremes and the extremes of healthcare. He joined the Aerospace medical association (AsMA) and the Space Surgical Association (SSA) in 2021. He is published and a presenter at conferences on this topic.
He became the Medical Director of Eva Medtec in September of 2022. Eva Medtec is the creator of Neuroglide, a system of automated therapy devices which provide effective, convenient, and sustainable medical devices for pain management options. Neuroglide is Class II FDA approved, emulating manual lymphatic drainage (MLD). Research is ongoing for Neuroglide therapeutic benefits and detailing the mechanisms of action from the lymphatics to cellular level.
He resides in the suburbs of Minneapolis, Minnesota with his wife of 37 years